United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

recordati pharmaceuticals ltd - sodium dihydrogen phosphate dihydrate; disodium hydrogen phosphate dodecahydrate - enema - 181mg/1ml ; 80mg/1ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

unimed unihealth pharmaceuticals ltd. - disodium hydrogen phosphate dodecahydrate + sodium dihydrogen phosphate dihydrate - oral solution - 24 gm + 54.22 gm/100 ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspire pharma ltd - sodium dihydrogen phosphate anhydrous; sodium bicarbonate - suppository - 340mg ; 250mg

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - epoetin alfa 16.8 µg/ml - solution for injection - 16.8 mcg/ml - active: epoetin alfa 16.8 µg/ml excipient: dibasic sodium phosphate dihydrate glycine hydrochloric acid monobasic sodium phosphate dihydrate nitrogen polysorbate 80 sodium chloride sodium hydroxide water for injection - binocrit is indicated for: · the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients with renal insufficiency not yet undergoing dialysis · anaemia associated with chronic renal failure in paediatric and adult patients on dialysis · anaemia in patients with non-myeloid malignancies where anaemia is due to the effect of concomitantly administered chemotherapy · adult patients with mild-to-moderate anaemia (haemoglobin > 100 to < 130 g/l) scheduled for elective surgery with an expected moderate blood loss (2-4 units or 900 to 1800 ml) to reduce exposure to allogeneic blood transfusion and to facilitate erythropoietic recovery · to augment autologous blood collection and to limit the decline in haemoglobin in anaemic adult patients undergoing major surgery who are not expected to pre-deposit their complete peri-operative blood needs.

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - epoetin alfa 336 µg/ml - solution for injection - 336 mcg/ml - active: epoetin alfa 336 µg/ml excipient: dibasic sodium phosphate dihydrate glycine hydrochloric acid monobasic sodium phosphate dihydrate nitrogen polysorbate 80 sodium chloride sodium hydroxide water for injection - binocrit is indicated for: · the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients with renal insufficiency not yet undergoing dialysis · anaemia associated with chronic renal failure in paediatric and adult patients on dialysis · anaemia in patients with non-myeloid malignancies where anaemia is due to the effect of concomitantly administered chemotherapy · adult patients with mild-to-moderate anaemia (haemoglobin > 100 to < 130 g/l) scheduled for elective surgery with an expected moderate blood loss (2-4 units or 900 to 1800 ml) to reduce exposure to allogeneic blood transfusion and to facilitate erythropoietic recovery · to augment autologous blood collection and to limit the decline in haemoglobin in anaemic adult patients undergoing major surgery who are not expected to pre-deposit their complete peri-operative blood needs.

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - epoetin alfa 84 µg/ml - solution for injection - 84 mcg/ml - active: epoetin alfa 84 µg/ml excipient: dibasic sodium phosphate dihydrate glycine hydrochloric acid monobasic sodium phosphate dihydrate nitrogen polysorbate 80 sodium chloride sodium hydroxide water for injection - binocrit is indicated for: · the treatment of severe anaemia of renal origin accompanied by clinical symptoms in patients with renal insufficiency not yet undergoing dialysis · anaemia associated with chronic renal failure in paediatric and adult patients on dialysis · anaemia in patients with non-myeloid malignancies where anaemia is due to the effect of concomitantly administered chemotherapy · adult patients with mild-to-moderate anaemia (haemoglobin > 100 to < 130 g/l) scheduled for elective surgery with an expected moderate blood loss (2-4 units or 900 to 1800 ml) to reduce exposure to allogeneic blood transfusion and to facilitate erythropoietic recovery · to augment autologous blood collection and to limit the decline in haemoglobin in anaemic adult patients undergoing major surgery who are not expected to pre-deposit their complete peri-operative blood needs.

United Kingdom - English - VMD (Veterinary Medicines Directorate)

b. braun vet care gmbh - glucose, magnesium chloride hexahydrate, potassium chloride, sodium chloride, sodium dihydrogen phosphate dihydrate, sodium lactate -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alturix ltd - sodium dihydrogen phosphate anhydrous - effervescent tablet - 1.936gram

New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - sodium valproate 100 mg/ml - solution for injection - 100 mg/ml - active: sodium valproate 100 mg/ml excipient: dibasic sodium phosphate dodecahydrate monobasic sodium phosphate dihydrate phosphoric acid sodium hydroxide water for injection - the treatment of patients with epilepsy or bipolar disorder, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

Singapore - English - HSA (Health Sciences Authority)

b. braun singapore pte ltd - alanine; arginine; aspartic acid; calcium chloride dihydrate; glucose monohydrate eqv to anhydrous glucose 120.0g/1000ml; glutamic acid; glycine; histidine hydrochloride monohydrate eqv to histidine 1.20g/1000ml; isoleucine; leucine; lysine hydrochloride eqv to lysine 2.184g/1000ml; magnesium acetate tetrahydrate; methionine; omega-3-acid triglycerides; phenylalanine; potassium acetate; proline; serine; sodium acetate trihydrate; sodium chloride; sodium dihydrogen phosphate dihydrate; sodium hydroxide; soya-bean oil, refined; threonine; triglycerides, medium chain; tryptophan; valine; zinc acetate dihydrate - injection, emulsion - alanine 4.656g/1000ml; arginine 2.592g/1000ml; aspartic acid 1.440g/1000ml; calcium chloride dihydrate 0.470g/1000ml; glucose monohydrate eqv to anhydrous glucose 120.0g/1000ml 132.0g/1000ml; glutamic acid 3.368g/1000ml; glycine 1.584g/1000ml; histidine hydrochloride monohydrate eqv to histidine 1.20g/1000ml 1.624g/1000ml; isoleucine 2.256g/1000ml; leucine 3.008g/1000ml; lysine hydrochloride eqv to lysine 2.184g/1000ml 2.728g/1000ml; magnesium acetate tetrahydrate 0.686g/1000ml; methionine 1.880g/1000ml; omega-3-acid triglycerides 4.00g/1000ml; phenylalanine 3.368g/1000ml; potassium acetate 2.747g/1000ml; proline 3.264g/1000ml; serine 2.880g/1000ml; sodium acetate trihydrate 0.222g/1000ml; sodium chloride 0.402g/1000ml; sodium dihydrogen phosphate dihydrate 1.872g/1000ml; sodium hydroxide 0.781g/1000ml; soya-bean oil, refined 16.00g/1000ml; threonine 1.744g/1000ml; triglycerides, medium chain 20.00g/1000ml; tryptophan 0.544g/1000ml; valine 2.496g/1000ml; zinc acetate dihydrate 5.264mg/1000ml